TSE:OGI Organigram (OGI) Stock Price, News & Analysis C$1.59 +0.01 (+0.63%) As of 09/4/2026 03:59 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsInsider TradesNews and Trends About Organigram Stock (TSE:OGI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Organigram alerts:Sign Up Key Stats Today's RangeC$1.58▼C$1.6050-Day RangeC$1.23▼C$1.7852-Week RangeC$1.20▼C$3.09Volume43,373 shsAverage Volume211,345 shsMarket CapitalizationC$229.20 millionP/E Ratio2.65Dividend YieldN/APrice TargetC$3.13Consensus RatingBuy Company Overview Organigram Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships. Read More Organigram Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks59th Percentile Overall ScoreOGI MarketRank™: Organigram scored higher than 59% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingOrganigram has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 2 buy ratings, no hold ratings, and no sell ratings.Upside PotentialOrganigram has a consensus price target of C$3.13, representing about 96.5% upside from its current price of C$1.59.Amount of Analyst CoverageOrganigram has received no research coverage in the past 90 days.Read more about Organigram's stock forecast and price target. Earnings and Valuation3.1 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Organigram is 2.65, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.04.Price to Earnings Ratio vs. SectorThe P/E ratio of Organigram is 2.65, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.10.Price to Earnings Growth RatioOrganigram has a PEG Ratio of 0.42. PEG Ratios below 1 indicate that a company could be undervalued.Price to Book Value per Share RatioOrganigram has a P/B Ratio of 0.44. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for OGI. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldOrganigram does not currently pay a dividend.Dividend GrowthOrganigram does not have a long track record of dividend growth. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 2 people have searched for OGI on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Organigram insiders have not sold or bought any company stock.Percentage Held by Insiders31.32% of the stock of Organigram is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions3.64% of the stock of Organigram is held by institutions.Read more about Organigram's insider trading history. Receive OGI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Organigram and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OGI Stock News HeadlinesOrganigram Global Inc. (OGI:CA) Q3 2026 Earnings Call TranscriptAugust 11, 2026 | seekingalpha.comOrganigram surges 10% on record Q3 resultsAugust 11, 2026 | seekingalpha.comGold majors have a big problemNewmont spent 15 billion dollars acquiring Newcrest in 2023, the largest deal in gold mining history. Yet production stayed at 5.9 million ounces, unchanged from 2020. Newmont, Barrick and Agnico all face the same reserve shortage, pushing majors toward acquiring smaller producing miners. Recent deals show the pattern: Rupert Resources jumped 67 percent and G2 Goldfields jumped 79 percent the day their buyouts were announced. Analyst Garrett Goggin has identified four junior miners he believes are next on the shopping list.September 6 at 1:00 AM | Golden Portfolio (Ad)Organigram global Q3 earnings previewAugust 10, 2026 | msn.comOrganigram Global Inc OGIJuly 7, 2026 | morningstar.comMAnalysts Offer Insights on Healthcare Companies: Organigram Global (OGI) and NeuroOne Medical Technologies (NMTC)May 14, 2026 | theglobeandmail.comCannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI)May 12, 2026 | finance.yahoo.comOrganigram Global Inc.April 13, 2026 | barrons.comSee More Headlines OGI Stock Analysis - Frequently Asked Questions How have OGI shares performed this year? Organigram's stock was trading at C$2.31 at the beginning of 2026. Since then, OGI shares have decreased by 31.2% and is now trading at C$1.59. How were Organigram's earnings last quarter? Organigram Holdings Inc. (TSE:OGI) released its earnings results on Tuesday, August, 11th. The company reported $0.77 earnings per share for the quarter. The firm had revenue of $105.78 million for the quarter. Organigram had a trailing twelve-month return on equity of 21.99% and a net margin of 28.02%. How do I buy shares of Organigram? Shares of OGI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Organigram own? Based on aggregate information from My MarketBeat watchlists, some other companies that Organigram investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Innovative Industrial Properties (IIPR), Aurora Cannabis (ACB), Canopy Growth (WEED), Aphria (APHA) and NVIDIA (NVDA). Company Calendar Last Earnings8/11/2026Today9/06/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeTSE SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolTSE:OGI CIKN/A Webwww.organigram.ca Phone844-644-4726FaxN/AEmployees987Year FoundedN/APrice Target and Rating Average Price Target for OrganigramC$3.13 High Price TargetC$3.25 Low Price TargetC$3.00 Potential Upside/Downside+96.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)C$0.60 Trailing P/E Ratio2.65 Forward P/E Ratio9.74 P/E Growth0.42Net Income-C$57.23 million Net Margins28.02% Pretax MarginN/A Return on Equity21.99% Return on Assets-5.56% Debt Debt-to-Equity Ratio6.48 Current Ratio2.61 Quick Ratio2.62 Sales & Book Value Annual SalesC$309.18 million Price / Sales0.74 Cash FlowC$0.41 per share Price / Cash Flow3.85 Book ValueC$3.59 per share Price / Book0.44Miscellaneous Outstanding Shares144,153,000Free FloatN/AMarket CapC$229.20 million OptionableNot Optionable Beta1.78 The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (TSE:OGI) was last updated on 9/6/2026 by MarketBeat.com Staff. From Our PartnersThis looks like plywood. It's not.AI data centers have a power problem nobody likes to talk about. A single rack of computers can now use more e...Eagle Publishing | SponsoredElon Musk’s Hushed FCC Filing. Sept 25th.Elon Musk quietly filed a document with the federal government tied to artificial intelligence, one of the lar...Paradigm Press | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredMajor Buy Alert Issued for September 30thKeith Kaplan has invested $17 million into his own AI research tools, building a platform now used by 180,000 ...TradeSmith | SponsoredWhy the Treasury still prices gold at 42 dollars an ounceThe U.S. Treasury still values its gold reserves at 42.22 dollars an ounce, a price set in 1973. Gold trades n...Golden Portfolio | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThe REAL Reason Trump is Invading IranFor a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
